Target intelligence / Profile preview

Bacterial 23S ribosomal RNA (23S rRNA) cryptic site (23S rRNA)

Target
23S rRNA
Molecular classification
Ribosomal RNA [1], Ribonucleoprotein [1]
01

Overview

The Bacterial 50S ribosomal subunit – 23S rRNA cryptic site refers to a specialized binding region within the 23S ribosomal RNA (rRNA) that is not constitutively open but becomes accessible through conformational changes upon ligand binding [1, 2]. Located primarily within the peptidyl transferase center (PTC) and the nascent peptide exit tunnel (NPET), this site is essential for the catalytic formation of peptide bonds and the subsequent passage of the growing protein chain [1, 3]. It is the primary target for several important classes of antibiotics, including oxazolidinones (e.g., linezolid) and pleuromutilins (e.g., lefamulin), which exploit the flexibility of the rRNA to exert their inhibitory effects [2, 3, 5]. By occupying this cryptic pocket, these drugs interfere with the positioning of aminoacyl-tRNA or physically obstruct the exit tunnel, effectively halting bacterial protein synthesis [1, 2]. While highly selective for bacterial ribosomes, the structural similarity between the 23S rRNA and human mitochondrial rRNA can lead to off-target effects and clinical safety concerns such as myelosuppression [1, 4]. Understanding the dynamics of this cryptic site is crucial for overcoming antibiotic resistance, which often arises from mutations in the rRNA or enzymatic modifications that prevent drug access to the pocket [4, 5].

Other names
23S ribosomal RNAPeptidyl transferase center (PTC)Nascent peptide exit tunnel (NPET)50S ribosomal subunit A-siteRibosomal RNA cryptic pocket
02

Mechanism of action

Inhibition of bacterial protein synthesis by binding to the 23S rRNA at the peptidyl transferase center (PTC) or the nascent peptide exit tunnel (NPET), which prevents the proper positioning of tRNA or blocks the progression of the growing peptide chain [1, 2, 3].

03

Biological functions

Protein synthesis [1]Translation [1]Peptidyl transferase activity [2]
04

Disease associations

Infection [1]
05

Safety considerations

Mitochondrial protein synthesis inhibition [1, 4]Myelosuppression [4]Optic and peripheral neuropathy [4]Serotonin syndrome [4]
06

Interacting drugs

Linezolid [2, 4]

5 more in the full profile.

07

Biomarkers

23S rRNA G2576T mutation [4]cfr methyltransferase gene [4]Linezolid-resistant Staphylococcus aureus (LRSA) screening [4]

Beyond the preview

Go deeper on Bacterial 23S ribosomal RNA (23S rRNA) cryptic site (23S rRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial 23S ribosomal RNA (23S rRNA) cryptic site (23S rRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call